102 related articles for article (PubMed ID: 15670764)
1. Susceptibility to streptozotocin-induced diabetes is mapped to mouse chromosome 11.
Babaya N; Ikegami H; Fujisawa T; Nojima K; Itoi-Babaya M; Inoue K; Ohno T; Shibata M; Ogihara T
Biochem Biophys Res Commun; 2005 Mar; 328(1):158-64. PubMed ID: 15670764
[TBL] [Abstract][Full Text] [Related]
2. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
3. The idd4 locus displays sex-specific epistatic effects on type 1 diabetes susceptibility in nonobese diabetic mice.
Ivakine EA; Mortin-Toth SM; Gulban OM; Valova A; Canty A; Scott C; Danska JS
Diabetes; 2006 Dec; 55(12):3611-9. PubMed ID: 17130511
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice.
Mensah-Brown EP; Al Rabesi Z; Shahin A; Al Shamsi M; Arsenijevic N; Hsu DK; Liu FT; Lukic ML
Clin Immunol; 2009 Jan; 130(1):83-8. PubMed ID: 18845486
[TBL] [Abstract][Full Text] [Related]
5. Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus.
Mi QS; Zhou L; Grattan M; Wang ZZ; Sivilotti M; She JX; Delovitch TL
Ann N Y Acad Sci; 2006 Oct; 1079():147-52. PubMed ID: 17130546
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes.
Gonzalez C; Cuvellier S; Hue-Beauvais C; Lévi-Strauss M
Diabetologia; 2003 Sep; 46(9):1291-5. PubMed ID: 12879252
[TBL] [Abstract][Full Text] [Related]
7. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
8. Congenic mapping and candidate gene analysis for streptozotocin-induced diabetes susceptibility locus on mouse chromosome 11.
Maegawa T; Miyasaka Y; Kobayashi M; Babaya N; Ikegami H; Horio F; Takahashi M; Ohno T
Mamm Genome; 2018 Apr; 29(3-4):273-280. PubMed ID: 29523950
[TBL] [Abstract][Full Text] [Related]
9. Congenic mapping of the MHC-linked susceptibility to type 1 diabetes in the NOD mouse: at least two genes contribute to the Idd16 effect.
Hiromine Y; Fujisawa T; Noso S; Babaya N; Kawabata Y; Ikegami H
Ann N Y Acad Sci; 2008 Dec; 1150():90-2. PubMed ID: 19120274
[TBL] [Abstract][Full Text] [Related]
10. [Early induction of diabetes in NOD mice by streptozotocin].
Orlow S; Yasunami R; Boitard C; Bach JF
C R Acad Sci III; 1987; 304(3):77-8. PubMed ID: 2949801
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1.
Cornall RJ; Prins JB; Todd JA; Pressey A; DeLarato NH; Wicker LS; Peterson LB
Nature; 1991 Sep; 353(6341):262-5. PubMed ID: 1832743
[TBL] [Abstract][Full Text] [Related]
12. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
13. Prolactin regulation of the expression of TNF-alpha, IFN-gamma and IL-10 by splenocytes in murine multiple low dose streptozotocin diabetes.
Lau J; Börjesson A; Holstad M; Sandler S
Immunol Lett; 2006 Jan; 102(1):25-30. PubMed ID: 16054232
[TBL] [Abstract][Full Text] [Related]
14. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse.
Ikegami H; Fujisawa T; Sakamoto T; Makino S; Ogihara T
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S85-90. PubMed ID: 15563987
[TBL] [Abstract][Full Text] [Related]
15. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes susceptibility genes on mouse chromosome 11 under high sucrose environment.
Kobayashi M; Ueda H; Babaya N; Itoi-Babaya M; Noso S; Fujisawa T; Horio F; Ikegami H
BMC Genet; 2020 Jul; 21(1):81. PubMed ID: 32703163
[TBL] [Abstract][Full Text] [Related]
17. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
18. Identification of the inflammasome Nlrp1b as the candidate gene conferring diabetes risk at the Idd4.1 locus in the nonobese diabetic mouse.
Motta VN; Markle JG; Gulban O; Mortin-Toth S; Liao KC; Mogridge J; Steward CA; Danska JS
J Immunol; 2015 Jun; 194(12):5663-73. PubMed ID: 25964492
[TBL] [Abstract][Full Text] [Related]
19. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
20. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
